Mo Yin Mok - Search Results

Year	Number of Results
2004	3
2005	4
2007	4
2008	2
2009	5
2010	12
2011	10
2012	4
2013	5
2014	6
2015	6
2016	7
2017	5
2019	1
2020	1
2021	1
2022	2
2023	2
2024	0

1

2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout.

Lorenzo JPP, Sollano MHMZ, Salido EO, Li-Yu J, Tankeh-Torres SA, Wulansari Manuaba IAR, Rahman MM, Paul BJ, Mok MY, De Silva M, Padhan P, Lim AL, Marcial M, Vicera JJ, Haq SA, Salman S, Liyanage CK, Keen HI, Yew Kuang C, Wei JC, Hellmi RY, Chan CE Jr, Louthrenoo W. Lorenzo JPP, et al. Among authors: mok my. Int J Rheum Dis. 2022 Jan;25(1):7-20. doi: 10.1111/1756-185X.14266. Epub 2021 Dec 20. Int J Rheum Dis. 2022. PMID: 34931463

2

IL-33 Orchestrated the Interaction and Immunoregulatory Functions of Alternatively Activated Macrophages and Regulatory T Cells In Vitro.

Mok MY, Luo CY, Huang FP, Kong WY, Chan GCF. Mok MY, et al. J Immunol. 2023 Oct 1;211(7):1134-1143. doi: 10.4049/jimmunol.2300191. J Immunol. 2023. PMID: 37566486

3

Recent advances and current state of immunotherapy in systemic lupus erythematosus.

Mok MY, Shoenfeld Y. Mok MY, et al. Expert Opin Biol Ther. 2016 Jul;16(7):927-39. doi: 10.1517/14712598.2016.1171840. Epub 2016 Apr 8. Expert Opin Biol Ther. 2016. PMID: 27032059 Review.

4

The burden and measurement of cardiovascular disease in SSc.

Mok MY, Lau CS. Mok MY, et al. Nat Rev Rheumatol. 2010 Jul;6(7):430-4. doi: 10.1038/nrrheum.2010.65. Epub 2010 Jun 1. Nat Rev Rheumatol. 2010. PMID: 20517296 Review.

5

Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells.

Mok MY, Law KS, Kong WY, Luo CY, Asfaw ET, Chan KW, Huang FP, Lau CS, Chan GCF. Mok MY, et al. J Innate Immun. 2023;15(1):485-498. doi: 10.1159/000529931. Epub 2023 Mar 8. J Innate Immun. 2023. PMID: 36889298 Free PMC article.

6

Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus.

Chan VS, Nie YJ, Shen N, Yan S, Mok MY, Lau CS. Chan VS, et al. Among authors: mok my. Autoimmun Rev. 2012 Oct;11(12):890-7. doi: 10.1016/j.autrev.2012.03.004. Epub 2012 Mar 20. Autoimmun Rev. 2012. PMID: 22503660 Review.

7

Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.

Mok MY. Mok MY. Int J Rheum Dis. 2015 Feb;18(2):250-9. doi: 10.1111/1756-185X.12532. Epub 2014 Dec 31. Int J Rheum Dis. 2015. PMID: 25639676 Review.

8

'Treat to target' for rheumatoid arthritis in 2014--time tested triple therapy or logical biologics?

Mok MY, Danda D. Mok MY, et al. Int J Rheum Dis. 2014 Jan;17(1):1-3. doi: 10.1111/1756-185X.12313. Int J Rheum Dis. 2014. PMID: 24472259 No abstract available.

9

Pregnancy outcome in patients with adult onset Still's disease.

Mok MY, Lo Y, Leung PY, Lau CS. Mok MY, et al. J Rheumatol. 2004 Nov;31(11):2307-9. J Rheumatol. 2004. PMID: 15517651 Review.

10

The immunological basis of B-cell therapy in systemic lupus erythematosus.

Mok MY. Mok MY. Int J Rheum Dis. 2010 Feb 1;13(1):3-11. doi: 10.1111/j.1756-185X.2009.01458.x. Int J Rheum Dis. 2010. PMID: 20374380 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

64 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year